Selected article for: "effective vaccine and mortality rate"

Author: Guqin Zhang; Chang Hu; Linjie Luo; Fang Fang; Yongfeng Chen; Jianguo Li; Zhiyong Peng; Huaqin Pan
Title: Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China
  • Document date: 2020_3_6
  • ID: jir7n19b_3
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.02.20030452 doi: medRxiv preprint 4 injury and acute kidney injury, resulting in a higher mortality rate. 10 11 However, the clinical features between severe and non-severe cases have not yet been well described. Unlike SARS-CoV, the SARS-CoV-2 displays a highly contagious infectiousness even during the asymptomatic period 12 . At present.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.02.20030452 doi: medRxiv preprint 4 injury and acute kidney injury, resulting in a higher mortality rate. 10 11 However, the clinical features between severe and non-severe cases have not yet been well described. Unlike SARS-CoV, the SARS-CoV-2 displays a highly contagious infectiousness even during the asymptomatic period 12 . At present, there is no effective medication nor vaccine for the SARS-CoV-2 infection. As of February 22, 2020, the National Health Commission of China has reported a total of 76,936 confirmed, 4,148 suspected cases and 2442 deaths in 31 provinces across the country. 13 In addition, more than 2700 confirmed cases have also been reported abroad in 26 different countries. 14 In this study, we have performed a comprehensive exploration of the epidemiological, clinical, laboratory and radiological characteristics of 221 hospitalized patients with laboratory-confirmed COVID-19, including 55 severe patients and 166 non-severe patients of Zhongnan Hospital of Wuhan University, Wuhan, China, from January 2 to February 10, 2020.

    Search related documents:
    Co phrase search for related documents
    • asymptomatic period and high mortality rate: 1
    • asymptomatic period and kidney injury: 1
    • asymptomatic period and mortality rate: 1, 2, 3
    • asymptomatic period and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
    • asymptomatic period and severe patient: 1, 2, 3
    • clinical feature and high mortality rate: 1, 2
    • clinical feature and kidney injury: 1, 2, 3, 4
    • clinical feature and mortality rate: 1, 2, 3, 4, 5, 6, 7
    • clinical feature and radiological characteristic: 1
    • clinical feature and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • clinical feature and severe patient: 1
    • comprehensive exploration and SARS infection: 1, 2, 3
    • confirm case and SARS infection: 1, 2, 3, 4
    • confirm case and severe patient: 1, 2
    • confirm total and SARS infection: 1, 2
    • different country and high mortality rate: 1, 2, 3
    • different country and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • different country and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • effective medication and high mortality rate: 1